Navigation Links
BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Date:7/28/2009

BIRMINGHAM, Ala., July 28 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its second quarter 2009 financial results will be released on Thursday, July 30, 2009. BioCryst will host a conference call and Web cast at 11:00 a.m. Eastern Time to discuss the financial results and provide an update on the Company's programs. The call will be led by Jon P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief Financial Officer and Dr. William P. Sheridan, Chief Medical Officer.

The Web cast can be accessed by logging onto http://www.biocryst.com. Please connect to the Web site at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed. To participate in the conference call, please dial 1-877-627-6566 (United States) or 1-719-325-4922 (International). No passcode is needed for the call. The audio portion of the Web cast will be archived and available for replay for at least 14 days.

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in oncology, infectious and autoimmune diseases. BioCryst has two product candidates in pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to expand its portfolio of next-generation therapeutic candidates with the potential to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
2. BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
3. BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
4. BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
5. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
6. BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
7. BioCryst to Present at the JMP Healthcare Focus Conference
8. BioCryst to Present at UBS 2008 Global Life Sciences Conference
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
11. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... GENEVA , July 11, 2014 ... pleased to announce the appointment of John P. ... Campus Biotech   in  Geneva . ... on Campus Biotech in Geneva , ... internationally recognised neuroscientists. John P. Donoghue , founder ...
(Date:7/10/2014)... 10, 2014 Women in the ... to an additional family planning option. Sayana® Press ... at all levels of the health system and ... a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with ... is the first of four African countries expected ...
(Date:7/10/2014)... Terascala, the industry leader in HPC ... former vice president of product management for Flexera Software, ... marketing. Terascala’s software when combined with leading compute and ... performance and most reliable solutions for processing big data. ... expansion and broaden its product portfolio. His leadership in ...
(Date:7/10/2014)... July 10, 2014 EvoDerma ’s NOOME ... This rejuvenating device now comes with a second treatment cup ... time. , The new cup is thinner on the edges ... to target rough, thin and uneven surfaces on the face, ... for a stimulating treatment on areas such as the cheeks ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... largest series of business-to-business IT events, is coming to Milwaukee again ... tradeshow and exposition will feature both global and Wisconsin-area technology companies. ... Gateway , Juniper Networks , Agilent , ... Solutions and Road Runner Business Class and other ...
... Middleton-based Bone Care International Inc. announced on Wednesday that ... , ,Genzyme and Bone Care have signed a definitive agreement ... all-cash transaction valued at $33.00 per fully diluted ... Bone Care's shareholders at a meeting on June 30, and ...
... bypass around Fond du Lac, Wis., opens later this ... a bridge like no other in the country. ... help to speed bridge-deck construction Externally, the bridge ... concrete deck reinforced with a novel fiber-reinforced polymer (FRP) ...
Cached Biology Technology:Polymer grid technology a boon for bridges 2Polymer grid technology a boon for bridges 3
(Date:7/11/2014)... eastern New South Wales, Australia when NASA,s Aqua satellite ... on July 11 (12:35 p.m. local time/11:35 p.m. EDT ... South Wales (NSW), the Moderate Resolution Imaging Spectroradiometer (MODIS) ... and spotted smoke (light brown) from various fires. Actively ... in red. , The New South Wales, Australia Government ...
(Date:7/11/2014)... The University of Chicago is creating a new ... at the University,s Institute for Molecular Engineering and ... million donation from the Millicent and Eugene Bell ... will reside within the Institute for Molecular Engineering. ... research project at the MBL,s Eugene Bell Center ...
(Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
Breaking Biology News(10 mins):New professorship in tissue engineering links molecular engineering, marine biology 2
... fuel emissions, planting new forests, or managing existing forests ... ability to act as a carbon sink. Research published ... Management shows that although planting trees alone is unlikely ... a significant effect in the longer term. Rik ...
... Rochelle, NY, April 7, 2008 The American Medical ... of women in medicine and the improvement of women,s ... ) as its official journal. Journal of Womens Health ... Inc ( http://www.liebertpub.com ). We are proud to ...
... documentary An Inconvenient Truth is a powerful example of ... audience. What is up for debate is whether it ... caused by human activities. Climate change experts express their ... in articles just published online in Springers journal, GeoJournal. ...
Cached Biology News:Forests' long-term potential for carbon offsetting 2Scientists debate the accuracy of Al Gore's documentary 'An Inconvenient Truth' 2
...
...
... is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
... DNase (patent pending) was developed using a protein ... the DNA binding pocket of wild-type DNase I. ... protein for DNA. The result is a versatile ... DNA, and an ability to maintain at least ...
Biology Products: